Literature DB >> 4394413

Local vascular changes induced by the cocarcinogen, phorbol myristate acetate.

A Janoff, A Klassen, W Troll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4394413

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094).

Authors:  K M Tramposch; F C Zusi; S A Marathe; P L Stanley; X Nair; S A Steiner; J W Quigley
Journal:  Agents Actions       Date:  1990-06

2.  Vascular permeability changes by proteinase inhibitors in carrageenin-induced inflammation in rats.

Authors:  K Watanabe; H Nakagawa; S Tsurufuji
Journal:  Agents Actions       Date:  1986-03

3.  On the biochemical mechanism of tumorigenesis in mouse skin. V. Studies of the metabolism of tumor promoting and non promoting phorbol derivatives in vivo and in vitro.

Authors:  G Kreibich; R Süss; V Kinzel
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

4.  Reactive oxygen in the tumor promotion stage of skin carcinogenesis.

Authors:  S M Fischer; G S Cameron; J K Baldwin; D W Jasheway; K E Patrick
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

5.  Vascular changes in rabbit skin induced by proinflammatory phorbol and 12-deoxyphorbol esters.

Authors:  T J Williams; J Westwick; E M Williamson; F J Evans
Journal:  Inflammation       Date:  1981-03       Impact factor: 4.092

6.  Mechanisms of lysosomal enzyme release from human polymorphonuclear leukocytes. Effects of phorbol myristate acetate.

Authors:  I M Goldstein; S T Hoffstein; G Weissmann
Journal:  J Cell Biol       Date:  1975-09       Impact factor: 10.539

7.  The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets.

Authors:  M B Zucker; W Troll; S Belman
Journal:  J Cell Biol       Date:  1974-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.